BioSpace News Archive

CymaBay Therapeutics, Inc. announced it will make three presentations at the European Association for the Study of the Liver ‘s The International Liver Congress™ 2023.

Vir Biotechnology, Inc. announced that five abstracts highlighting new data from the Company’s broad hepatitis portfolio addressing both hepatitis B virus and hepatitis D virus have been accepted for presentation at the annual meeting of the European Association for the Study of the Liver, EASL™ Congress 2023, taking place in Vienna from June 21-24.

XNK Therapeutics announced the appointment of Hugo Petit as Chief Financial Officer and member of the company’s leadership team.

MRM Health - a clinical-stage biopharmaceutical company focused on developing innovative microbiome-based biotherapeutics based on its proprietary and unique CORAL® platform technology - announced that it appointed Katja Conrath, PhD, as Chief Scientific Officer.

Curasight A/S is pleased to announce preclinical data demonstrating the effectiveness of uTREAT® in treating aggressive brain cancer.

While several effective treatments are currently available for the treatment of alcohol withdrawal syndrome, there is an unmet medical need in the abstinence maintenance phase.

Axol Bioscience Ltd., a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease patient samples.

Dizal presented compelling data of its robust oncology portfolio at the 2023 American Society of Clinical Oncology Annual Meeting taking place June 2-6, 2023, in Chicago.

RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the hiring of Owen Watson, MS.

NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.